The smart healthcare company, MiiS, announced that it has signed an exclusive distribution agreement with Clairvo Technologies, a subsidiary which is responsible for digital healthcare businesses in Marubeni Group. According to the agreement, Clairvo will sell and market MiiS’ eye fundus camera with edge computing AI-based software "AI-DR (Diabetic Retinopathy)" in Japan. This is a major milestone for MiiS’ product to penetrate the Japanese market and endorse Company’s commitment to explore the new markets.

Marubeni represents a large-scale, comprehensive trading company in Japan that manages products and provides value-added services across the board. Its subsidiary, Clairvo Technologies, has been developing most advanced technologies and excellent products to the healthcare industry ｔin Japan and Asian countries. The collaboration between MiiS and Clairvo has been moving on in great progress for two years, and recently the AI-DR software has obtained approval by a registered certification body under Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices in Japan and received a Class II medical device certificate, making a significant progress for strategic partnership. Clairvo plans to sell the products to medical and long-term nursing care institutions.

In addition to the Japanese market, MiiS also aims to cultivate the Southeast Asian market. Several products are currently under registration for local licenses. MiiS is confidently hoping that through market expanding the market expansion, MiiS will bring advanced technology and products to every corner of the world.

For full release please visit www.miis.com.tw